MEI Pharma Renamed to Litecoin Strategy, Stock Price Rises 10.61%

Wednesday, Sep 10, 2025 3:19 pm ET1min read

Litecoin Strategy, formerly MEI Pharma, has changed its name and is currently trading up 10.61% with a market capitalization of $101 million.

September 10, 2025 — Litecoin Strategy, formerly known as MEI Pharma, has undergone a significant rebranding, changing its name to Litecoin Strategy and its stock ticker symbol from MEIP to LITS. This announcement was made on September 10, with the rebranding taking effect at the market open on September 11, 2025 Litecoin Treasury Company MEI Pharma Announces Rebranding to Lite Strategy[2].

The rebranding coincides with the company's appointment of Litecoin founder Charlie Lee to its board of directors. This strategic move aims to capitalize on the growing interest in Litecoin and its potential as a digital currency.

Following the rebranding announcement, Litecoin Strategy's shares surged intraday, with a 10.61% increase in value. The company's market capitalization reached approximately $101 million based on real-time market data MEI Pharma Rebrands as Litecoin Strategy (LITS) — Shares Surge 10.61%, Market Cap Reaches $101M[3]. This significant increase in share value underscores the market's positive response to the rebranding and the addition of Charlie Lee to the board.

Investors and market participants are advised to review the company's official regulatory disclosures and SEC filings for authoritative details regarding the rebrand and any material corporate developments MEI Pharma Rebrands as Litecoin Strategy (LITS) — Shares Surge 10.61%, Market Cap Reaches $101M[3].

Grayscale, a prominent cryptocurrency investment company, has also submitted separate S-1 filings with the SEC for a Hedera ETF and S-3 filings for a Litecoin ETF, further indicating the growing interest in Litecoin and its potential as a viable investment option Grayscale has filed the S-1 for the Hedera ETF and the S-3 for the Litecoin ETF.[1].

The rebranding and strategic appointments at Litecoin Strategy signal a shift towards a more prominent role in the cryptocurrency market. As Litecoin continues to gain traction, investors will closely watch the company's performance and the potential impact of these changes on its future prospects.

MEI Pharma Renamed to Litecoin Strategy, Stock Price Rises 10.61%

Comments



Add a public comment...
No comments

No comments yet